- Patent Title: Targeting cancer cells selectively via resonant harmonic excitation
-
Application No.: US15373916Application Date: 2016-12-09
-
Publication No.: US11097130B2Publication Date: 2021-08-24
- Inventor: Michael Ortiz , Stefanie Heyden
- Applicant: California Institute of Technology
- Applicant Address: US CA Pasadena
- Assignee: California Institute of Technology
- Current Assignee: California Institute of Technology
- Current Assignee Address: US CA Pasadena
- Agency: KPPB LLP
- Main IPC: A61N7/00
- IPC: A61N7/00

Abstract:
Systems and methods for targeting specific cell types by selective application of ultrasonic harmonic excitation at their resonance frequency (“oncotripsy”) are presented. The systems and methods result in the lysis of targeted cell types by using ultrasonic harmonic excitations that have been specifically tuned to disrupt the nuclear membrane of the targeted cells types by inducing a destructive vibrational response therein while leaving non-targeted cell types intact. The target cells types may be cancerous cells.
Public/Granted literature
- US20170165506A1 Targeting Cancer Cells Selectively Via Resonant Harmonic Excitation Public/Granted day:2017-06-15
Information query